effect
irradi
major
histocompat
complex
mhc
express
lymphocyt
infiltr
normal
rat
brain
gliosarcoma
brain
tumor
model
examin
dose
irradi
administ
biolog
equival
use
treatment
patient
malign
glioma
signific
chang
immun
paramet
observ
follow
irradi
normal
rat
brain
gliosarcoma
model
irradi
suppress
mhc
express
lymphocyt
infiltr
find
suggest
prior
exposur
therapeut
irradi
need
advers
affect
subsequ
immunotherapi
provid
foundat
futur
studi
immunomodul
irradi
brain
limit
current
therapi
patient
malign
glioma
led
renew
interest
immunotherapi
adjunct
mode
treatment
immunotherapi
like
effect
earli
week
follow
maxim
cytoreduct
surgeri
radiat
therapi
immunosuppress
effect
ioniz
radiat
well
known
marko
saluk
irradi
shown
decreas
major
histocompat
complex
mhc
express
lymphocyt
infiltr
melanoma
jager
et
al
reduc
effect
form
immunotherapi
ettinghausen
et
al
howev
certain
circumst
irradi
enhanc
host
immun
respons
increas
efficaci
immunotherapeut
regimen
hellstrom
et
al
tilkin
et
al
north
recent
work
defin
grow
number
patholog
experiment
situat
brain
immun
environ
alter
lampson
yet
studi
address
possibl
effect
irradi
immun
paramet
normal
tumorbear
brain
studi
examin
effect
irradi
biolog
equival
use
treatment
patient
malign
glioma
time
period
immunotherapi
like
attempt
mhc
express
lymphocyt
infiltr
examin
irradi
tumorfre
brain
gliosarcoma
brain
tumor
model
rat
femal
cdf
rat
g
purchas
charl
river
lab
wilmington
usa
antibodi
immunocytochemistri
carri
rabbit
serum
glial
fibrillari
acid
protein
gfap
dako
monoclon
antibodi
class
ii
class
mhc
lca
cell
helper
cytotoxicsuppressor
b
cell
microglia
use
modif
abc
vectastain
procedur
whelan
et
al
briefli
section
fix
absolut
methanol
min
incub
success
normal
goat
serum
rain
dilut
primari
antibodi
overnight
biotinyl
hors
antimous
igg
preincub
rain
normal
rat
serum
reduc
background
stain
min
abc
complex
h
primari
antibodi
dilut
except
dilut
specif
bind
visual
solut
contain
diaminobenzidin
tetrahydrochlorid
hydrogen
peroxid
imidazol
min
cultur
supernat
use
neg
control
gfap
stain
section
serial
incub
normal
goat
serum
rabbit
anticow
gfap
antibodi
biotinyl
goat
antirabbit
igg
remaind
procedur
unchang
one
outlin
normal
rabbit
serum
use
neg
control
irradi
tumorfre
brain
posterior
half
brain
anesthet
rat
irradi
singl
dose
cgi
use
ge
maximar
xray
gener
dose
biolog
equival
high
dose
fraction
radiat
use
clinic
treatment
patient
malign
glioma
elli
kramer
et
al
henderson
et
al
lead
foil
block
shield
anterior
half
brain
act
intern
control
two
unirradi
rat
serv
addit
control
anim
sacrif
day
immedi
irradi
week
coron
frozen
section
brain
obtain
irradi
pariet
lobe
shield
frontal
lobe
examin
histolog
chang
hematoxylin
eosin
h
e
demyelin
luxol
fast
blue
immunocytochem
section
correspond
area
brain
unirradi
rat
serv
addit
control
normal
lymph
node
brain
two
rat
unit
recombin
tinterferon
ifnt
biogen
biolog
inject
pariet
lobe
day
prior
sacrif
serv
posit
control
irradi
tumorbear
anim
gliosarcoma
cell
line
origin
deriv
tumor
induc
cdf
rat
weekli
intraven
inject
nnitrosomethylurea
schmidek
et
al
x
cell
stereotact
implant
right
caudat
nucleu
cdf
rat
use
modif
method
kobayashi
kobayashi
et
al
day
implant
half
anim
anesthet
whole
brain
irradi
singl
dose
cgi
irradi
nonirradi
rat
sacrif
day
although
attempt
made
match
irradi
nonirradi
control
close
possibl
none
nonirradi
tumorbear
anim
surviv
beyond
day
day
implant
coron
frozen
section
obtain
center
tumor
assay
immunocytochem
antibodi
percentag
posit
stain
cellstot
number
cell
six
random
highpow
field
within
tumor
minimum
cell
obtain
averag
determin
whelan
et
al
normal
rat
brain
irradi
produc
signific
histolog
chang
demyelin
gliosi
within
time
period
studi
monoclon
antibodi
class
mhc
antigen
produc
dens
stain
lymph
node
control
dendrit
cell
control
brain
treat
differ
detect
stain
pattern
irradi
brain
area
compar
unirradi
area
normal
brain
class
restrict
blood
vessel
wall
class
ii
occasion
cell
associ
leptomening
choroid
plexu
blood
vessel
rare
dendrit
cell
antibodi
lca
produc
strong
stain
lymphoid
control
stain
occasion
inflammatori
cell
leptomening
irradi
unirradi
area
control
brain
fig
unirradi
tumorbear
anim
strong
class
activ
seen
tumor
cell
surround
neural
cell
contrast
mani
class
ii
cell
seen
especi
peripheri
tumor
number
class
ii
cell
increas
time
tumor
implant
reach
ceil
within
select
area
tumor
mass
class
ii
cell
dendrit
morpholog
suggest
microglia
rare
cell
morpholog
characterist
macrophag
lymphocyt
occasion
astrocyt
neither
number
proport
cell
significantli
chang
follow
irradi
identif
confirm
serial
section
stain
antibodi
gfap
two
kind
evid
suggest
class
iiposit
cell
tumor
cell
vitro
class
ii
detect
cell
even
incub
ifnt
suggest
cell
may
potenti
express
class
ii
mhc
molecul
work
report
separ
cell
transfect
escherichia
coli
flgalactosidas
gene
could
identifi
histochem
lampson
et
al
doublelabel
studi
use
modifi
cell
reveal
class
iiposit
tumor
cell
within
brain
mani
infiltr
leucocyt
also
seen
tumorcontain
area
mani
cell
within
tumor
lca
analysi
lymphocyt
subset
show
mani
cell
includ
helper
cell
cell
within
tumor
mass
fewer
cytotoxicsuppressor
cell
rare
b
cell
less
control
studi
cell
crossreact
antibodi
lymphocyt
subset
irradi
produc
slight
necrosi
signific
effect
class
mhc
express
tumorbear
rat
signific
chang
note
class
ii
mhc
express
lymphocyt
infiltr
first
day
irradi
day
onward
slight
increas
number
class
iiposit
cell
lymphocyt
irradi
tumor
howev
differ
reach
statist
signific
wilcoxon
sign
rank
test
fig
normal
circumst
littl
detect
mhc
express
neural
cell
lymphocyt
infiltr
brain
howev
enhanc
mhc
express
lymphocyt
infiltr
occur
varieti
condit
enabl
neural
cell
becom
subject
cellmedi
immun
reaction
sobel
et
al
wong
et
al
lampson
hickey
suzumura
et
al
lampson
traugott
mcgeer
et
al
streit
et
al
studi
found
dose
irradi
biolog
equival
use
treatment
malign
glioma
produc
major
histolog
chang
leucocyt
infiltr
induct
mhc
antigen
brain
time
cover
surprisingli
studi
also
suggest
irradi
decreas
class
ii
mhc
express
lymphocyt
infiltr
gliosarcoma
brain
tumor
model
find
lay
foundat
futur
studi
immunomodul
brain
case
brain
tumor
patient
high
dose
radiotherapi
given
previous
